
A peptide is a short chain of amino acids, typically 2 to 50, linked by chemical bonds called peptide bonds, according to the National Human Genome Research Institute (NHGRI). Peptide therapy is a general, non-medical label for using a specific peptide or peptide-based product as a treatment. Because many different peptides exist, the label tells you very little on its own.
What are peptides?
Peptides are molecules made of amino acids, the same building blocks that make up proteins. The body makes many peptides naturally. Peptides used in medicine are specific substances, each with its own structure and intended use.
Are all peptide therapies the same?
No. Different peptides are different substances. They may have very different intended uses, doses, side effects and levels of research. A statement about one peptide does not apply to another, and claims made about "peptides" as a group should be treated with caution.
Why does the regulatory status of a peptide matter?
Regulatory status differs from product to product:
- FDA-approved peptide-based medications. Some medications based on peptides have FDA-approved uses. For example, semaglutide, described by the National Library of Medicine as a polypeptide analogue of the hormone GLP-1, is available in FDA-approved brand-name products for specific uses (LiverTox). Approval applies to a specific product and use, not to peptides in general.
- Compounded preparations. Peptides may also be prepared by compounding pharmacies. The FDA states that compounded drugs are not FDA-approved, which means the FDA does not review their safety, effectiveness or quality before they are marketed.
- Substances with safety concerns or limited data. The FDA maintains a list of bulk drug substances that may present significant safety risks when used in compounding, which has included certain peptides, and the FDA updates that list over time. Some peptides also have limited research in people.
- Products sold without a prescription. Products marketed online for "research use" or without medical oversight are outside this discussion and may not contain what their labels state.
Why does the exact product matter?
Because evidence, risks and regulatory status differ by peptide and by product, the exact substance, its source and its intended use determine what can responsibly be said about it. Ask for the specific name, not a general description such as "a peptide."
Why do medical supervision and evaluation matter?
A medical evaluation allows a licensed provider to review your health history, current medications and goals, consider lab work when appropriate, and decide whether any peptide-based treatment may be appropriate, or whether another approach may be more appropriate. Supervision also allows follow-up to review side effects and decide whether to continue, change or stop treatment.
What should I ask before considering peptide therapy?
- What is the exact name of the peptide or product being considered, and what is it intended to do in my situation?
- Is it an FDA-approved medication for this use, a compounded preparation, or something else? Which pharmacy prepares it?
- What evidence exists for this specific peptide and use, and what is still unknown?
- What are the possible side effects and interactions with my current medications?
- How will I be monitored, and how will we decide whether to continue or stop?
- What are the alternatives, including not using a peptide, and what is the total cost?
What are the limitations and considerations?
Peptide treatment is not appropriate for everyone. Research varies widely by substance, some products are not FDA-approved, and individual responses differ. General information about "peptides" cannot tell you whether a specific product may be appropriate for you.
Peptide consultations at Synergy Health
Synergy Health offers physician-supervised consultations at our Trinity and Ocala locations for patients who want to discuss peptide-based treatments. You can read about the services listed on our site, metabolic peptide therapy and recovery and performance peptides, and our Weight & Metabolism care. This article is general education; whether any specific peptide is discussed or recommended for you is determined by a licensed provider after an individual evaluation.
Medical Disclaimer: This content is provided for general educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Treatment options, risks, potential benefits, eligibility, and expected outcomes vary by individual and by the specific treatment being considered. A consultation and medical evaluation are necessary to determine whether a treatment may be appropriate for you.
Frequently asked questions
Peptides are short chains of amino acids, typically 2 to 50, linked by peptide bonds. The body makes many peptides naturally.
Peptide therapy is a general label for using a specific peptide or peptide-based product as a treatment. Because many different peptides exist, the label alone does not describe what a treatment is, how well it has been studied or its regulatory status.
No. Different peptides are different substances with different intended uses, side effects, evidence and regulatory status. Some peptide-based medications have FDA-approved uses; compounded preparations are not FDA-approved.
Peptide-based treatments used as medicine should be prescribed and monitored by a licensed provider who reviews your health history and medications and can decide whether to continue, change or stop treatment.
There is no general eligibility. Whether any specific peptide-based treatment may be appropriate depends on the product and on your health history, medications and goals, and is determined by a licensed provider after a medical evaluation.
Ask for the exact product name and intended use, whether it is FDA-approved for that use or compounded, what evidence exists, possible side effects and interactions, how you will be monitored, the alternatives and the total cost.
Sources
- National Human Genome Research Institute (NIH), Talking Glossary: Peptide
- National Library of Medicine (NIH), LiverTox: Semaglutide
- U.S. Food and Drug Administration, Understanding the Risks of Compounded Drugs
- U.S. Food and Drug Administration, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
External sources are provided for general reference and were reviewed in October 2026.
Learn more about your options.
Request a consultation in Trinity or Ocala to ask your questions. Whether any treatment may be appropriate for you is determined after a medical evaluation.